ADMA-46.82%20.0%
DYN-21.75%20.0%
INSM-36.87%20.0%
IONS-44.02%20.0%
NBIX+1.22%20.0%
As of Oct 2, 2026, 9:55 PM ET
Rare Diseases '25: RNA Therapy & Protein Mod Constituents
ADMA Biologics, Inc.ADMA | 20.0% | -2.11% | -1.12% | 2.00% | -2.32% | -46.82% | -37.70% | -52.05% | -33.24% | -50.33% | 716.81% | $2.25B |
Dyne Therapeutics, Inc.DYN | 20.0% | -3.92% | -10.71% | -39.12% | -3.26% | -21.75% | -2.02% | 54.44% | 21.95% | -54.69% | -5.41% | $2.84B |
Insmed IncorporatedINSM | 20.0% | 2.33% | -9.07% | -13.24% | 1.17% | -36.87% | -26.43% | 49.60% | -28.10% | 55.63% | 305.84% | $24.09B |
Ionis Pharmaceuticals, Inc.IONS | 20.0% | -1.05% | -3.20% | -27.79% | 0.65% | -44.02% | -45.43% | 54.25% | -35.26% | 15.15% | 29.70% | $7.24B |
Neurocrine Biosciences, Inc.NBIX | 20.0% | 1.76% | 0.92% | -9.02% | 2.02% | 1.22% | 8.55% | 32.54% | 4.98% | 27.98% | 41.12% | $14.40B |
| Theme return | — | -0.60% | -4.64% | -17.89% | -0.35% | -26.55% | -18.09% | 37.63% | -7.83% | 4.63% | 241.57% | — |
| Average | 20.0% | -0.60% | -4.64% | -17.43% | -0.35% | -29.65% | -20.61% | 27.76% | -13.93% | -1.25% | 217.61% | $10.16B |
| Median | 20.0% | -1.05% | -3.20% | -13.24% | 0.65% | -36.87% | -26.43% | 49.60% | -28.10% | 15.15% | 41.12% | $7.24B |
| Std Dev | 0.0% | 2.35% | 4.51% | 14.45% | 2.06% | 17.71% | 20.68% | 40.70% | 23.12% | 43.87% | 273.20% | $8.20B |
| Min | 20.0% | -3.92% | -10.71% | -39.12% | -3.26% | -46.82% | -45.43% | -52.05% | -35.26% | -54.69% | -5.41% | $2.25B |
| Max | 20.0% | 2.33% | 0.92% | 2.00% | 2.02% | 1.22% | 8.55% | 54.44% | 21.95% | 55.63% | 716.81% | $24.09B |
| % Positive Tickers | 40.00% | 20.00% | 20.00% | 60.00% | 20.00% | 20.00% | 80.00% | 40.00% | 60.00% | 80.00% |
Default: Wgt ↓ · Click headers to sort · Shift+click secondaryWgt ↓ · Scroll right · Tap headers to sort